← Leaderboards
Joseph Charles Cooley
University Of Colorado Denver
$395,430
Attributed
$395,430
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $156.8K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$395,430 · 2
By mechanism
K08$313,632 · 1
F32$81,798 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Livia Agnes Veress$8,631,906
- James V Degregori$21,700,379
- Donald Ym Leung$75,548,590
- Daniel G Foster$102,469
- Ronald J Sokol$193,385,254
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsMouse ModelFibroblastsOralLaboratoriesMentorsContractsFamily MemberIdiopathic Pulmonary FibrosisIn VitroEffector CellExtracellular MatrixLungBleomycinAutomobile DrivingCareerApoptosisDepositionApoptoticFibrosisBcl2 GeneClinically RelevantBehaviorPhysicians
Grant awards (5)
Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling$156,816
K08 · FY2025 · HL · contact PI
Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling$156,816
K08 · FY2024 · HL · contact PI
Targeting Bcl-2 Family Proteins to Facilitate Fibroblast Apoptosis and Promote the Resolution of Pulmonary Fibrosis$3,699
F32 · FY2022 · HL · contact PI
Targeting Bcl-2 Family Proteins to Facilitate Fibroblast Apoptosis and Promote the Resolution of Pulmonary Fibrosis$2,500
F32 · FY2022 · HL · contact PI
Targeting Bcl-2 Family Proteins to Facilitate Fibroblast Apoptosis and Promote the Resolution of Pulmonary Fibrosis$75,599
F32 · FY2021 · HL · contact PI